-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.2550.46% Upside
Standard BioTools Inc. Frequently Asked Questions
-
What analysts cover Standard BioTools Inc.?
Standard BioTools Inc. has been rated by research analysts at Jefferies in the past 90 days.